Google+ Safe Radiotherapy | Archive | Lung Cancer

Lung Cancer

Lung Cancer news and resources

Promising immunotherapy drug now available for some lung cancer patients in England

Promising immunotherapy drug now available for some lung cancer patients in England

Some lung cancer patients in England can now be offered a potentially life-extending immunotherapy drug. The National Institute for Health and Care Excellence (NICE) has said that nivolumab (Opdivo) should be made available to certain lung cancer patients in England through the Cancer Drugs Fund (CDF). Rose Gray, Cancer Research UK’s senior policy adviser, welcomed the decision […]

‘Epigenetic’ changes from cigarette smoke may be first step in lung cancer development

‘Epigenetic’ changes from cigarette smoke may be first step in lung cancer development

Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development. Epigenetic processes are essentially switches that control a gene’s potentially heritable levels of protein […]

Molecules That May Help Prevent Brain Tumor Development Identified

Molecules That May Help Prevent Brain Tumor Development Identified

Researchers from the University of Portsmouth’s Brain Tumour Research Centre of Excellence have identified molecules which are responsible for metastatic lung cancer cells binding to blood vessels in the brain. In order for a cancer cell to enter the brain, it must first bind to the cells which line the structure separating the blood from […]

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer

For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center. The research, published in JAMA Oncology, reported an overall survival (OS) of 26.5 months. In […]

First-line immunotherapy treatment can improve survival for subset of lung cancer patients

First-line immunotherapy treatment can improve survival for subset of lung cancer patients

Findings from a phase III clinical trial for advanced lung cancer patients could help oncologists better predict which patients are likely to receive the most benefit from immunotherapy as a first-line treatment based on the unique molecular characteristics of their tumor, according to a new study reported by a global team led by David Carbone, […]

Discovery could guide immunotherapy for lung cancer

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a Cancer Research UK funded study(link is external) published today (Monday) in Nature Immunology. Researchers at the University of Southampton(link is external) and La Jolla Institute for Allergy & Immunology, California(link is […]

Largest genome-wide study of lung cancer susceptibility identifies new causes

Largest genome-wide study of lung cancer susceptibility identifies new causes

A huge study identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk. Using the OncoArray genotyping platform developed by multiple cancer consortia, a recent large aggregated genomewide association study identifies new susceptibility loci for lung cancer, the leading cause of cancer mortality […]

Standard dosage for one lung cancer treatment may be too high

Standard dosage for one lung cancer treatment may be too high

A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment. In October 2016, pembrolizumab became the new standard of care for firstline treatment of patients with metastatic non-small cell lung […]

T cell revival correlates with lung cancer response to PD-1 immunotherapy

T cell revival correlates with lung cancer response to PD-1 immunotherapy

In lung cancer passives who were attracting immunotherapy narcotizes end the PD-1 pathway, rating for CD8 T cell activation in their blood unreservedly predicted whether their tumors wear wishes a draw back. The denouements are appointed for hebdomadal in PNAS. Benumbs butt PD-1 or its ligand PD-L1 re-activate “fatigued” CD8 T flats by promoting their […]

Fast capture of cancer markers will aid in diagnosis and treatment

Fast capture of cancer markers will aid in diagnosis and treatment

UNIVERSITY PARK, Pa. — A nanoscale product of human cells that was once considered junk is now known to play an important role in intercellular communication and in many disease processes, including cancer metastasis. Researchers at Penn State have developed nanoprobes to rapidly isolate these rare markers, called extracellular vesicles (EVs), for potential development of […]

Page 1 of 6123Next ›Last »